Literature DB >> 28447050

Prognostic impact of nodal status and therapeutic implications.

Katja Ott1, Susanne Blank2, Laura Ruspi3, Margit Bauer1, Leila Sisic2, Thomas Schmidt2.   

Abstract

The prognostic impact of lymph node (LN) metastases in gastric cancer is generally accepted. In primarily resected patients the pN-category and LN ratio are independent prognostic factors. Number of involved LNs, number of resected LNs, lymphangiosis and micrometastases also influence the prognosis significantly. To guarantee a proper D2 lymphadenectomy (LAD) at least 25 LNs according to the German S3 guidelines for the treatment of gastric cancer should be removed. Also in neoadjuvantly treated patients the ypN-category and LN ratio play an important prognostic role, despite the fact that UICC staging system was development based only on primarily resected patients. The role of response of LNs in neoadjuvantly treated patients is still unclear and needs further investigation. It seems to be less important than the response of the primary tumor. Limited data exists, suggesting that preoperative treatment might reduce the number of LNs involved and improve ypN-category. Due to further development in gastric cancer like laparoscopic resection and effective perioperative treatment in locally advanced tumor the role and the prognostic impact of LAD is again in the focus of discussion.

Entities:  

Keywords:  Lymph node metastases (LN metastases); neoadjuvant treatment; prognosis; therapeutic implications

Year:  2017        PMID: 28447050      PMCID: PMC5388622          DOI: 10.21037/tgh.2017.01.10

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  45 in total

1.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.

Authors:  Yanfeng Hu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Yingwei Xue; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Pingyan Chen; Hao Liu; Chaohui Zheng; Fenglin Liu; Jiang Yu; Ziyu Li; Gang Zhao; Xinzu Chen; Kuan Wang; Ping Li; Jiadi Xing; Guoxin Li
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

2.  Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer?

Authors:  A Biondi; D D'Ugo; F C M Cananzi; V Papa; A Borasi; F Sicoli; M Degiuli; G Doglietto; R Persiani
Journal:  Eur J Surg Oncol       Date:  2015-04-08       Impact factor: 4.424

3.  Clinical impact of the extent of lymph node micrometastasis in undifferentiated-type early gastric cancer.

Authors:  Tomohiro Lee; Hiroaki Tanaka; Masaichi Ohira; Yoshihiro Okita; Mami Yoshii; Katsunobu Sakurai; Takahiro Toyokawa; Naoshi Kubo; Kazuya Muguruma; Sayaka Tanaka; Masahiko Ohsawa; Kosei Hirakawa
Journal:  Oncology       Date:  2014-06-04       Impact factor: 2.935

4.  Prognostic significance of lymphovascular invasion in node-negative gastric cancer.

Authors:  Ju-Hee Lee; Min Gyu Kim; Min-Sung Jung; Sung Joon Kwon
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

5.  Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.

Authors:  Taeil Son; Woo Jin Hyung; Joong Ho Lee; Yoo Min Kim; Hyoung-Il Kim; Ji Yeong An; Jae-Ho Cheong; Sung Hoon Noh
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

6.  Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative.

Authors:  Sepideh Gholami; Lucas Janson; David J Worhunsky; Thuy B Tran; Malcolm Hart Squires; Linda X Jin; Gaya Spolverato; Konstantinos I Votanopoulos; Carl Schmidt; Sharon M Weber; Mark Bloomston; Clifford S Cho; Edward A Levine; Ryan C Fields; Timothy M Pawlik; Shishir K Maithel; Bradley Efron; Jeffrey A Norton; George A Poultsides
Journal:  J Am Coll Surg       Date:  2015-05-05       Impact factor: 6.113

7.  Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Authors:  X-J Wu; R-L Miao; Z-Y Li; Z-D Bu; L-H Zhang; A-W Wu; X-L Zong; S-X Li; F Shan; X Ji; H Ren; J-F Ji
Journal:  Eur J Surg Oncol       Date:  2015-04-03       Impact factor: 4.424

8.  Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.

Authors:  Yuan-Yuan Huang; Qiong Yang; Si-Wei Zhou; Ying Wei; Yan-Xian Chen; De-Rong Xie; Bei Zhang
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

9.  Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.

Authors:  Hongyong He; Zhenbin Shen; Xuefei Wang; Jing Qin; Yihong Sun; Xinyu Qin
Journal:  Jpn J Clin Oncol       Date:  2015-10-23       Impact factor: 3.019

Review 10.  Extent of lymph node dissection for adenocarcinoma of the stomach.

Authors:  Simone Mocellin; Peter McCulloch; Hussain Kazi; Joaquin J Gama-Rodrigues; Yuhong Yuan; Donato Nitti
Journal:  Cochrane Database Syst Rev       Date:  2015-08-12
View more
  4 in total

1.  Gastric cancer lymph node resection-the more the merrier?

Authors:  Henrik Nienhüser; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2018-01-05

2.  Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Authors:  Susanne Blank; Thomas Schmidt; Patrick Heger; Moritz J Strowitzki; Leila Sisic; Ulrike Heger; Henrik Nienhueser; Georg Martin Haag; Thomas Bruckner; André L Mihaljevic; Katja Ott; Markus W Büchler; Alexis Ulrich
Journal:  Gastric Cancer       Date:  2017-07-06       Impact factor: 7.370

3.  The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy.

Authors:  Karol Rawicz-Pruszyński; Bogumiła Ciseł; Radosław Mlak; Jerzy Mielko; Magdalena Skórzewska; Magdalena Kwietniewska; Agnieszka Pikuła; Katarzyna Gęca; Katarzyna Sędłak; Andrzej Kurylcio; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

4.  Ultrastaging Using Ex Vivo Sentinel Lymph Node Mapping and One-Step Nucleic Acid Amplification (OSNA) in Gastric Cancer: Experiences of a European Center.

Authors:  Bruno Märkl; Bianca Grosser; Kerstin Bauer; Dmytro Vlasenko; Gerhard Schenkirsch; Andreas Probst; Bernadette Kriening
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.